Physician
Laith Potrous MD PLLC
Laith Potrous MD PLLC was paid $3.98M by Medicaid between Feb 2022 and Dec 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoLAITH POTROUS MD PLLC
STERLING HEIGHTS, MI 48310
STERLING HEIGHTS, MI 48310
33aNPI1861155772assigned 10/18/2021
33bProvider typeFamily Medicine Physician
28Total paid$3.98M
24GClaims117,563
24DCodes billed52
24AFirst – last monthFeb 2022 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#25 of 826
Median peer was paid$98K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 19,450 | $714K | |
| 2023 | 41,988 | $1.53M | |
| 2024incomplete | 56,125 | $1.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 31,416 | 24,179 | $1.94M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 12,208 | 10,735 | $1.01M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 5,357 | 5,344 | $404K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.1% | 1,488 | 1,474 | $161K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.2% | 4,934 | 4,451 | $128K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.8% | 10,814 | 9,378 | $111K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 3,779 | 1,976 | $51K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,627 | 1,513 | $26K |
| 99401 | <1% | 1,425 | 1,275 | $26K | |
| 72100 | <1% | 1,026 | 1,014 | $21K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,089 | 5,750 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 943 | 921 | $13K |
40 more codes
| 72040 | <1% | 463 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,531 | $7K |
| 73560 | <1% | 367 | $6K | |
| 81003 | <1% | 3,961 | $6K | |
| 93000 | <1% | 894 | $6K | |
| 99000 | <1% | 6,061 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 587 | $3K |
| 73620 | <1% | 166 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,049 | $2K |
| 73120 | <1% | 127 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 537 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 126 | $2K |
| 69210 | <1% | 80 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 290 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,262 | $1K |
| 20610 | <1% | 45 | $1K | |
| 99402 | <1% | 23 | $948.39 | |
| 99195 | <1% | 17 | $916.95 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,027 | $904.04 |
| 78268 | <1% | 15 | $875.59 | |
| 96160 | <1% | 442 | $677.30 | |
| 16020 | <1% | 17 | $658.30 | |
| 90686 | <1% | 50 | $625.80 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $594.86 |
| 90756 | <1% | 14 | $359.34 | |
| 82962 | <1% | 207 | $343.34 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 178 | $336.71 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 835 | $286.44 |
| 73100 | <1% | 14 | $284.96 | |
| 99407 | <1% | 15 | $269.91 | |
| 73020 | <1% | 19 | $222.71 | |
| 81002 | <1% | 69 | $178.56 | |
| 81025 | <1% | 24 | $172.83 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 175 | $152.31 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $103.77 |
| 87807 | <1% | 13 | $76.82 | |
| 1111F | <1% | 282 | $0.01 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 6,104 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,278 | $0.00 |
| 36410 | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOTROUS, LAITH (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Family Care Urgent Care PLLC | Sterling Heights, MI | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.